Financhill
Buy
56

HIMS Quote, Financials, Valuation and Earnings

Last price:
$33.63
Seasonality move :
3.58%
Day range:
$34.30 - $37.69
52-week range:
$11.20 - $72.98
Dividend yield:
0%
P/E ratio:
64.28x
P/S ratio:
5.57x
P/B ratio:
16.18x
Volume:
23.4M
Avg. volume:
29.6M
1-year change:
139.88%
Market cap:
$7.7B
Revenue:
$1.5B
EPS (TTM):
$0.54

HIMS Analysts' Consensus Rating

The 12 analysts providing 12-month price projections for Hims & Hers Health shares anticipate an average target of $44.10, ranging from a low estimate of $21.00 to a high estimate of $85.00. This average target implies a growth of 27.04% compared to the current stock price of $34.71.

Consensus Price Target

$44.10

Highest Price Target

$85.00

Lowest Price Target

$21.00

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Analyst Ratings

6M Ago 1M Ago Current
Buy 5 4 4

Hold 8 7 7

Sell 0 1 1
Consensus Hold Hold Hold

HIMS Recommendation Trends

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Does Intel Stock Have Room to Grow?
Does Intel Stock Have Room to Grow?

Intel Corporation (NASDAQ:INTC)’s recent innovations, Xeon 6 SoC and Xeon®…

Is Walmart the Largest Retailer in the World?
Is Walmart the Largest Retailer in the World?

For many years, Walmart (NYSE:WMT) has been the world’s largest…

IBM Stock: Stable Dividend or Stagnant Investment?
IBM Stock: Stable Dividend or Stagnant Investment?

The AI race has heated up significantly but returns on…

Stock Ideas

Sell
49
Is AAPL Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 36x

Sell
44
Is MSFT Stock a Buy?

Market Cap: $2.8T
P/E Ratio: 32x

Sell
45
Is NVDA Stock a Buy?

Market Cap: $2.7T
P/E Ratio: 37x

Alerts

Sell
50
GH alert for Mar 12

Guardant Health [GH] is up 1.55% over the past day.

Sell
44
TER alert for Mar 12

Teradyne [TER] is down 0.17% over the past day.

Buy
57
LMB alert for Mar 12

Limbach Holdings [LMB] is down 4.89% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock